Telomerase inhibitors as novel antitumor drugs

被引：0
|
作者：
A. I. Glukhov
L. V. Svinareva
S. E. Severin
V. I. Shvets
机构：
[1] Sechenov Medical Academy,
[2] Moscow Research Institute of Medical Ecology,undefined
[3] Lomonosov Moscow State Academy of Fine Chemical Technology,undefined
来源：
Applied Biochemistry and Microbiology | 2011年 / 47卷
关键词：
antisense therapy; immortalization; G-quadruplex; ribozyme; RNA interference; telomerase activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Telomerase activity is detected in most types of human tumors, but it is almost undetectable in normal somatic cells; therefore, telomerase is a promising therapeutic target. The present review describes various approaches to telomerase inhibition, namely, antisense therapy, RNA interference, and the use of ribozymes and agents interacting with the telomeric G-quadruplex. The use of these compounds in clinical research is analyzed in the review.
引用
收藏
页码：655 / 660
页数：5
相关论文
共 50 条
  • [41] Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma
    Healy, Jason R.
    Schnepp, Robert W.
    Hart, Lori S.
    Raman, Pichai
    Danielson, Laura
    Russell, Michael
    Khurana, Priya
    Gagliardi, Maria
    Kinsey, Ryan M.
    Wyce, Anastasia
    Barbash, Olena
    Tummino, Peter J.
    Chesler, Louis
    Maris, John M.
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [42] Proteasome inhibitors: A novel class of potent and effective antitumor agents
    Adams, J
    Palombella, VJ
    Sausville, EA
    Johnson, J
    Destree, A
    Lazarus, DD
    Maas, J
    Pien, CS
    Prakash, S
    Elliott, PJ
    CANCER RESEARCH, 1999, 59 (11) : 2615 - 2622
  • [43] Synthesis and biological evaluation of quinoline-imidazole hybrids as potent telomerase inhibitors: a promising class of antitumor agents
    Duan, Yong-Tao
    Yao, Yong-Fang
    Tang, Dan-Jie
    Thumar, Nilesh J.
    Teraiya, Shashikant B.
    Makawana, Jigar A.
    Sang, Ya-Li
    Wang, Zhong-Chang
    Tao, Xiang-Xiang
    Jiang, Ai-Qin
    Zhu, Hai-Liang
    RSC ADVANCES, 2014, 4 (39) : 20382 - 20392
  • [44] Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532
    Liu, Chao
    Zhou, Hua
    Sheng, Xiao Bao
    Liu, Xin Hua
    Chen, Fei Hu
    BIOORGANIC CHEMISTRY, 2020, 102
  • [45] Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERT
    Kellermann, Guillaume
    Kaiser, Markus
    Dingli, Florent
    Lahuna, Olivier
    Naud-Martin, Delphine
    Mahuteau-Betzer, Florence
    Loew, Damarys
    Segal-Bendirdjian, Evelyne
    Teulade-Fichou, Marie-Paule
    Bombard, Sophie
    NUCLEIC ACIDS RESEARCH, 2015, 43 (15) : E99 - U55
  • [46] Targeting telomerase with radiolabeled inhibitors
    Waghorn, Philip A.
    Jackson, Mark R.
    Gouverneur, Veronique
    Vallis, Katherine A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 117 - 129
  • [47] In silico design of telomerase inhibitors
    Baginski, Maciej
    Serbakowska, Katarzyna
    DRUG DISCOVERY TODAY, 2020, 25 (07) : 1213 - 1222
  • [48] Genetic manipulation of antitumor-agent biosynthesis to produce novel drugs
    Salas, JA
    Méndez, C
    TRENDS IN BIOTECHNOLOGY, 1998, 16 (11) : 475 - 482
  • [49] Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
    Zhao, Hongqing
    Liu, Yang
    Cai, Na
    Liao, Xiaolin
    Tang, Lin
    Wang, Yuhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2143 - 2167
  • [50] Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes
    Prada, Patricia O.
    Saad, Mario J. A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 751 - 763
12345